Pith. sign in

REVIEW 4 major objections 6 minor 38 references

The need for statistical physics in Africa: perspective and an illustration in drug delivery problems

T0 review · 4 major / 6 minor · reviewed 2026-08-16 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read Atomistic simulations show lecithin nanolipids can carry the poorly soluble drug niclosamide, with loading improving as lecithin concentration rises.

desk verdict Worth reading for the Africa perspective; the MD illustration's headline claim about concentration-dependent loading capacity is not supported by the data. read the letter →

arxiv 2504.17452 v1 pith:PE5F4XNA submitted 2025-04-24 cond-mat.stat-mech physics.bio-phphysics.chem-phphysics.soc-ph

Mtabazi G. Sahini , Isaac Onoka , Said A.H. Vuai , Édgar Roldán , Hulda S. Swai , Daniel M. Shadrack This is my paper · ORCID
classification cond-mat.stat-mechphysics.bio-phphysics.chem-phphysics.soc-ph
keywords statisticalphysicsmoleculardynamicssimulationlecithinnanolipidniclosamidedrugdeliveryfreeenergylandscapeself-assemblypoorlywater-soluble
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper argues that statistical physics tools, specifically atomistic molecular dynamics, can address pressing health challenges in Africa, and illustrates this with a study of lecithin nanolipids as carriers for niclosamide, a poorly water-soluble drug. Through simulations, it claims that increasing lecithin concentration improves both the loading capacity and the interaction strength between the nanolipids and the drug, and that lecithin self-assembles into a spherical monolayer that binds niclosamide at the hydrophilic surface. The free-energy analysis identifies two metastable conformations of niclosamide separated by kinetic barriers, with the enol group either pointing toward or away from the keto group. If these results hold, lecithin concentration becomes a tunable design parameter for nanocarriers, and the work provides a template for using statistical physics in drug-delivery research.

What carries the argument

The key machinery is the free-energy surface (FES) computed from molecular dynamics trajectories via ΔF = −kBT ln(Px/P0), using as reaction coordinates the keto–enol distance dOH−O between atoms 1 and 7, the torsional angles φ (1-2-3-4) and ψ (4-5-6-8), and the centre-of-mass distance d between niclosamide and the lecithin cluster. These coordinates locate the metastable conformations, the kinetic barriers, and the bound/unbound states; the radius of gyration Rg is used to measure nanolipid size and compactness. The argument is carried by comparing free-energy minima, autocorrelation functions, and residence times across three lecithin concentrations (1, 4, and 128 lipids per drug molecule).

What would settle it

Run ten independent 500 ns simulations of the 1:128 lecithin–niclosamide system; if spherical monolayers with the drug bound at the headgroup surface form in fewer than half of the replicates, or if an isothermal titration calorimetry binding assay on lecithin–niclosamide mixtures shows no increase in bound drug fraction from 1:1 to 1:128 ratios, the central claim fails.

Watch

Extended reading notes

Core claim

The central claim is that atomistic molecular dynamics simulations show lecithin nanolipids spontaneously self-assembling into spherical monolayer structures in water and loading a single niclosamide molecule, with both the loading capacity and the strength of the lecithin–niclosamide interaction increasing with lecithin concentration. The free-energy landscape of niclosamide, built from the keto–enol distance and torsional angles, reveals two metastable conformations—the enol hydrogen pointing toward the keto group (α) and pointing away (β)—separated by barriers of about 4 kBT and 10 kBT for the two torsional degrees of freedom. At high lecithin concentration the centre-of-mass distance between drug and lipid shows damped oscillations that cannot be fit by a single exponential, indicating non-Markovian binding–unbinding dynamics with memory and inertial effects. The paper presents these findings as evidence that lecithin nanolipids are promising carriers for hydrophobic drugs, while stating that in vitro and in vivo validation remains essential.

Load-bearing premise

The results rest on the assumption that single molecular dynamics trajectories of 100–480 nanoseconds per system are long enough and reproducible enough to give the true self-assembled structure and converged free-energy landscape; if those runs are stuck in non-equilibrium states, the reported loading and conformational claims may be simulation artefacts.

Editorial extensions

If this is right

  • Lecithin concentration becomes a tunable handle for formulation: simulation predictions can guide which lecithin-to-drug ratio to test experimentally.
  • The two metastable conformations and their ~4–10 kBT barriers give quantitative targets for spectroscopic or calorimetric experiments on niclosamide in lipid environments.
  • Spontaneous formation of a spherical monolayer within about half a microsecond suggests nanolipid carriers can assemble without complex templating or external stabilizers.
  • The observed non-Markovian binding–unbinding dynamics implies that simple first-order release models may be inadequate, informing controlled-release design.
  • The same simulation workflow transfers to other poorly water-soluble drugs, making it a low-cost training vehicle for statistical physics in drug discovery.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The paper tests one drug molecule per up to 128 lipids, far from therapeutic loading; whether crowding or multiple drug molecules change the assembly mechanism is untested and would be a natural next step.
  • If loading capacity rises monotonically with lecithin concentration, there should exist an optimal ratio beyond which added lipid dilutes the drug or alters aggregate morphology; the paper does not probe this boundary.
  • The free-energy coordinates used here could be extended to compute release kinetics by comparing barrier heights in water versus lipid environments, yielding predictions testable by stopped-flow or fluorescence measurements.
  • Because the results come from single trajectories per system, the most direct validation would be replicate simulations and experimental binding assays; until then the quantitative loading claim is a simulation prediction, not an established fact.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 6 minor

Summary. This perspective article argues for the development of statistical physics in Africa and illustrates the argument with atomistic molecular dynamics simulations of lecithin nanolipids interacting with a single niclosamide molecule. The simulations are used to describe self-assembly of lecithin into spherical monolayer structures, to construct free-energy surfaces for niclosamide internal coordinates, and to report autocorrelation times for the lecithin-niclosamide center-of-mass distance. The abstract and introduction make the central claim that loading capacity and interaction strength between lecithin nanolipids and niclosamide improve with increased lecithin concentrations.

Significance. The perspective component, rooted in a two-week biophysics workshop in Morogoro, is a valuable contribution to the journal's community, and the paper honestly acknowledges the need for experimental validation. If the simulation claims were rigorously supported, the work would offer a simple design rule for lecithin-based nanocarriers and demonstrate the practical value of statistical physics for African research challenges. The paper also compares its conformational results with an external DFT study and clearly states its hypothesis about membrane permeation. However, the central quantitative claim about loading capacity and interaction strength is not supported by the observables actually computed, and the simulation evidence rests on single trajectories without convergence checks. The contribution is therefore preliminary and would require substantial revision to substantiate its headline conclusions.

major comments (4)
  1. [Abstract; Computational Methods; Results and Discussion (Fig. 6, Fig. 8)] The central claim that loading capacity and interaction strength improve with increased lecithin concentration is not measurable from the reported simulations. Each system contains exactly one niclosamide molecule (Computational Methods, system list), so no loading-capacity observable is defined; the radius-of-gyration FES (Fig. 8) reports aggregate compactness, not drug loading capacity, and is only shown for the 1:1 and 1:4 systems. For interaction strength, the only concentration-dependent comparison is the autocorrelation of the center-of-mass distance (Fig. 6), where the fits for the high-concentration systems are poor (R^2 = 0.7 and 0.8) and a shorter decorrelation time indicates faster fluctuations, not a deeper binding well. No binding free energy or PMF between the drug and the aggregate is computed as a function of lecithin amount. Please compute a proper binding free energy or PMF, or revise the abstract and conclusions to describe the observed structures and dynamics without the loading-capacity claim.
  2. [Computational Methods (system list)] The three systems do not realize a controlled concentration gradient. The box volumes are (3 nm)^3, (3.05 nm)^3, and (10.13 x 10.52 x 10.30) nm, so the lecithin number densities are non-monotonic: the 1:4 system has a higher number density (4/28.4 ≈ 0.141 nm^-3) than the 1:128 system (128/1097 ≈ 0.117 nm^-3). Moreover, the 1:1 and 1:4 systems contain isolated monomers or small clusters rather than self-assembled nanolipids, unlike the 1:128 system. The phrase 'increased lecithin concentration' therefore conflates cluster size, box volume, and molar concentration, and the observed trend cannot be causally attributed to concentration alone.
  3. [Results and Discussion: Free energy surfaces (Figs. 3, 4, 7, 8)] Each free-energy surface is constructed from a single production trajectory (100 ns for 1:1 and 1:4; 480 ns for 1:128) with no replica runs, block averaging, or time-dependent convergence diagnostics. For lipid self-assembly and drug binding, these timescales can be insufficient, and the reported barriers (e.g., ~4 kBT in Fig. 4a and ~10 kBT in Fig. 4b) and the two-state interpretation may reflect non-equilibrium artifacts. Please provide convergence checks (e.g., block-error analysis or multiple independent runs) and report uncertainties on the FES minima and barrier heights.
  4. [Results and Discussion: Residence time and kinetics (Table 2); Stochastic motion (Fig. 6)] Table 2 reports a residence time of 7.4e4 ps (koff = 1.3e-5 ps^-1) for the 4-5-6-8 torsion from a 100 ns simulation. This timescale exceeds the simulation length by several orders of magnitude, so it cannot be reliably estimated from the trajectory. Similarly, the quoted correlation times in Fig. 6 for the 1:4 and 1:128 systems are based on single-exponential fits with R^2 = 0.7 and 0.8, making the two-decimal precision unjustified; the authors themselves note damped oscillations that invalidate a simple exponential model. Either provide longer or accelerated sampling with proper error analysis, or remove the quantitative kinetic claims.
minor comments (6)
  1. [Throughout] The text repeatedly uses 'wander' where 'wonder' is intended (e.g., 'the reader may wander', 'Readers may now wander').
  2. [Computational Methods (system list)] The second bullet reads 'NIC 1:4 NIC' and should be 'NIC 1:4 LEC'.
  3. [Fig. 7 caption] There is a typo: 'concentratino' should be 'concentration'.
  4. [Fig. 5 caption] The caption contains 'The the red circle' with a duplicated article.
  5. [Computational Methods (water model citation)] The TIP3P water model is cited to Ref. [25] (Gereben and Pusztai), which discusses SPC/E and SWM4-DP; the original TIP3P citation (Jorgensen et al., 1983) should be used instead.
  6. [Results and Discussion: Stochastic motion] The text says 'see symbols in Fig. 8' when discussing the autocorrelation function, but the ACF is plotted in Fig. 6; the cross-reference is incorrect.

Circularity Check

0 steps flagged · score 0.0 of 10

No significant circularity: the simulation statistics are descriptive characterizations of the trajectories, and the cited prior work provides independent context rather than load-bearing premises.

full rationale

The derivation chain in this paper is not circular. The molecular dynamics simulations generate trajectories from which the free-energy surfaces (Figs. 3, 4, 7 and 8), center-of-mass distances (Fig. 5c), and autocorrelation functions (Fig. 6) are computed as direct statistics of the simulated data; no target result is inserted into the calculation. The reported correlation times are exponential fits to these autocorrelation functions and are descriptive quantities, not parameters fitted to the conclusion that loading improves with lecithin concentration. The comparison to DFT results [31] is an external, independent check of the niclosamide conformations. The only author self-citations ([8] and [14]) are contextual references to prior molecular dynamics work in Tanzania and to lecithin-phospholipid docking studies; they do not supply a load-bearing premise or a uniqueness theorem, and the central claims do not reduce to them. The abstract's claim that 'loading capacity and interaction strength' improve with lecithin concentration is weakened by the fact that each system contains a single niclosamide molecule and no binding free energy is computed, but that is a question of evidentiary support and experimental design, not circularity. No equation equates the claimed result with an input by construction, and no fitted parameter is renamed as a prediction. Scoring 0 is therefore appropriate.

Assumptions & free parameters 3 free parameters · 5 assumptions · 0 invented entities

The simulation relies on standard MD machinery and a single set of molecular structures. No new entities are postulated. The main assumptions are the force-field accuracy, the water model, the ad-hoc single-trajectory sampling, and the PRODRG topology quality.

free parameters (3)
  • Autocorrelation time tau (NIC 1:1 LEC) = 0.93 +/- 0.01 ns
    Fit to the autocorrelation function of the center-of-mass distance; descriptive, not load-bearing.
  • Autocorrelation time tau (NIC 1:4 LEC) = 0.35 +/- 0.01 ns
    Fit to the ACF; R^2=0.7, used to argue the process is not exponential.
  • Autocorrelation time tau (NIC 1:128 LEC) = 0.20 +/- 0.01 ns
    Fit to the ACF; R^2=0.8.
assumptions (5)
  • domain assumption GROMOS 54a7 force field accurately represents lecithin and niclosamide.
    All interaction energies depend on this force field; no validation against experiment or QM for this system is provided.
  • domain assumption TIP3P water model is adequate for lipid self-assembly simulations.
    Used for solvation; TIP3P is common but known to have limitations for lipid systems.
  • domain assumption A single MD trajectory of 100-480 ns samples the equilibrium ensemble and yields converged free-energy surfaces.
    No replica simulations or convergence tests are reported; lipid self-assembly is slow and may not be fully equilibrated.
  • domain assumption PRODRG-generated topologies are valid for these molecules.
    The paper acknowledges PRODRG limitations and says topologies were verified, but the verification is not documented.
  • standard math The free-energy estimate Delta F = -k_B T ln(P_x/P_0) follows from the Boltzmann distribution.
    Standard statistical mechanics for a histogram from a single trajectory.

how reviews work

0 comments
Cite this review

Pith. "Pith review of The need for statistical physics in Africa: perspective and an illustration in drug delivery problems." pith.science (2026). https://pith.science/paper/PE5F4XNA

@misc{pith2026250417452,
  author       = {Pith},
  title        = {Pith review of: The need for statistical physics in Africa: perspective and an illustration in drug delivery problems},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/PE5F4XNA}},
  note         = {Machine review of arXiv:2504.17452}
}
read the original abstract

The development of statistical physics in Africa is in its nascent stages, yet its application holds immense promise for advancing emerging research trends on the continent. This perspective paper, a product of a two-week workshop on biophysics in Morogoro (Tanzania), aims to illuminate the potential of statistical physics in regional scientific research. We employ in-silico atomistic molecular dynamics simulations to investigate the loading and delivery capabilities of lecithin nanolipids for niclosamide, a poorly water-soluble drug. Our simulations reveal that the loading capacity and interaction strength between lecithin nanolipids and niclosamide improve with increased lecithin concentrations. We perform a free-energy landscape analysis which uncovers two distinct metastable conformations of niclosamide within both the aqueous phase and the lecithin nanolipids. Over a simulation period of half a microsecond, lecithin nanolipids self-assemble into a spherical monolayer structure, providing detailed atomic-level insights into their interactions with niclosamide. These findings underscore the potential of lecithin nanolipids as efficient drug delivery systems.

Figures

Figures reproduced from arXiv: 2504.17452 by the authors.

Figure 1
Figure 1. Illustration of the chemical structure of various [PITH_FULL_IMAGE:figures/full_fig_p003_1.png] view at source ↗
Figure 3
Figure 3. 2D free-energy surface of niclosamide (colormap) [PITH_FULL_IMAGE:figures/full_fig_p004_3.png] view at source ↗
Figure 4
Figure 4. 1D free-energy surfaces associated with the (a) [PITH_FULL_IMAGE:figures/full_fig_p005_4.png] view at source ↗
Figures from the paper (4 more)
Figure 5
Figure 5. Figure 5: Formation of self-assembled lecithin monolayer with a single loaded niclosamide: (a) stages for self-assembly [PITH_FULL_IMAGE:figures/full_fig_p006_5.png]
Figure 6
Figure 6. Figure 6: Autocorrelation function associated with the [PITH_FULL_IMAGE:figures/full_fig_p007_6.png]
Figure 8
Figure 8. Figure 8: 1D Free energy as a function of the radius of gy [PITH_FULL_IMAGE:figures/full_fig_p008_8.png]
Figure 7
Figure 7. Figure 7: (a) 1D free energy surface for NIC 1:128 LEC [PITH_FULL_IMAGE:figures/full_fig_p008_7.png]

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

38 extracted references · 38 canonical work pages

  1. [1]

    E. B. Mpemba and D. G. Osborne, “Cool?,” Physics Ed- ucation, vol. 4, no. 3, pp. 172–175, 1969

    work page 1969

  2. [2]

    Mpemba index and anomalous relaxation,

    I. Klich, O. Raz, O. Hirschberg, and M. Vucelja, “Mpemba index and anomalous relaxation,” Physical Re- view X, vol. 9, no. 2, p. 021060, 2019

    work page 2019

  3. [3]

    A fresh understanding of the mpemba effect,

    J. Bechhoefer, A. Kumar, and R. Ch´ etrite, “A fresh understanding of the mpemba effect,” Nature Reviews Physics, vol. 3, no. 8, pp. 534–535, 2021

    work page 2021

  4. [4]

    Thermodynamics of the quantum mpemba effect,

    M. Moroder, O. Culhane, K. Zawadzki, and J. Goold, “Thermodynamics of the quantum mpemba effect,” Phys- ical Review Letters, vol. 133, no. 14, p. 140404, 2024

    work page 2024

  5. [5]

    Heating and cooling are fundamentally asymmet- ric and evolve along distinct pathways,

    M. Ib´ anez, C. Dieball, A. Lasanta, A. Godec, and R. A. Rica, “Heating and cooling are fundamentally asymmet- ric and evolve along distinct pathways,” Nature Physics, vol. 20, no. 1, pp. 135–141, 2024

    work page 2024

  6. [6]

    Modulational instability in the cubic–quintic nonlinear schr¨ odinger equation through the variational approach,

    F. I. Ndzana, A. Mohamadou, and T. C. Kofan´ e, “Modulational instability in the cubic–quintic nonlinear schr¨ odinger equation through the variational approach,” Optics communications, vol. 275, no. 2, pp. 421–428, 2007

    work page 2007

  7. [7]

    Modeling the dynamics of novel coronavirus (2019-ncov) with fractional derivative,

    M. A. Khan and A. Atangana, “Modeling the dynamics of novel coronavirus (2019-ncov) with fractional derivative,” Alexandria Engineering Journal, vol. 59, no. 4, pp. 2379– 2389, 2020

    work page 2019

  8. [8]

    Luteolin: a blocker of sars-cov-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynam- ics,

    D. M. Shadrack, G. Deogratias, L. W. Kiruri, I. Onoka, J.-M. Vianney, H. Swai, and S. S. Nyandoro, “Luteolin: a blocker of sars-cov-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynam- ics,” Journal of Molecular Modeling , vol. 27, pp. 1–15, 2021

    work page 2021

Show all 38 references
  1. [9]

    A minimal model of dy- namical phase transition,

    P. T. Nyawo and H. Touchette, “A minimal model of dy- namical phase transition,” Europhysics Letters, vol. 116, no. 5, p. 50009, 2017

    2017

  2. [10]

    Phospholipids: Unique carriers for drug delivery sys- tems,

    R. P. Singh, H. Gangadharappa, and K. Mruthunjaya, “Phospholipids: Unique carriers for drug delivery sys- tems,” Journal of Drug Delivery Science and Technology , vol. 39, pp. 166–179, 2017

    2017

  3. [11]

    In- jectable lipid emulsions?advancements, opportunities and challenges,

    K. Hippalgaonkar, S. Majumdar, and V. Kansara, “In- jectable lipid emulsions?advancements, opportunities and challenges,” Aaps Pharmscitech, vol. 11, no. 4, pp. 1526– 1540, 2010

    2010

  4. [12]

    Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine,

    C. Rupp, H. Steckel, and B. W. M¨ uller, “Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine,” International journal of pharmaceutics, vol. 395, no. 1-2, pp. 272–280, 2010

    2010

  5. [13]

    Liposomal drug delivery systems: from concept to clinical applications,

    T. M. Allen and P. R. Cullis, “Liposomal drug delivery systems: from concept to clinical applications,” Advanced drug delivery reviews , vol. 65, no. 1, pp. 36–48, 2013

    2013

  6. [14]

    Phospholipids dock sars-cov-2 spike protein via hydrophobic interactions: a minimal in- silico study of lecithin nasal spray therapy,

    M. N. Qaisrani, R. Belousov, J. U. Rehman, E. M. Goli- aei, I. Girotto, R. Franklin-Mergarejo, O. G¨ uell, A. Has- sanali, and ´E. Rold´ an, “Phospholipids dock sars-cov-2 spike protein via hydrophobic interactions: a minimal in- silico study of lecithin nasal spray therapy,”T...

    2021

  7. [15]

    Phytosomes: the new technology for enhancement of bioavailability of botanicals and nu- traceuticals,

    S. Bhattacharya, “Phytosomes: the new technology for enhancement of bioavailability of botanicals and nu- traceuticals,” International Journal of Health Research , vol. 2, no. 3, pp. 225–232, 2009

    2009

  8. [16]

    The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease,

    J. N. van der Veen, J. P. Kennelly, S. Wan, J. E. Vance, D. E. Vance, and R. L. Jacobs, “The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease,” Biochimica et Bio- physica Acta (BBA)-Biomembranes , vol. 1859, no. 9, pp. 1558–1572, 2017

    2017

  9. [17]

    Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, cur- cumin, green tea, and grape seed extracts,

    P. M. Kidd, “Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, cur- cumin, green tea, and grape seed extracts,” Altern Med Rev, vol. 14, no. 3, pp. 226–46, 2009

    2009

  10. [18]

    Ad- vances in lipid nanodispersions for parenteral drug de- livery and targeting,

    P. P. Constantinides, M. V. Chaubal, and R. Shorr, “Ad- vances in lipid nanodispersions for parenteral drug de- livery and targeting,” Advanced drug delivery reviews , vol. 60, no. 6, pp. 757–767, 2008

    2008

  11. [19]

    Pre- clinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer,

    C.-K. Lin, M.-Y. Bai, T.-M. Hu, Y.-C. Wang, T.-K. Chao, S.-J. Weng, R.-L. Huang, P.-H. Su, and H.-C. Lai, “Pre- clinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer,” Oncotarget, vol. 7, no. 8, p. 8993, 2016

    2016

  12. [20]

    Gromacs: High perfor- mance molecular simulations through multi-level paral- lelism from laptops to supercomputers,

    M. J. Abraham, T. Murtola, R. Schulz, S. P´ all, J. C. Smith, B. Hess, and E. Lindahl, “Gromacs: High perfor- mance molecular simulations through multi-level paral- lelism from laptops to supercomputers,”SoftwareX, vol. 1, pp. 19–25, 2015

    2015

  13. [21]

    Def- inition and testing of the gromos force-field versions 54a7 and 54b7,

    N. Schmid, A. P. Eichenberger, A. Choutko, S. Riniker, M. Winger, A. E. Mark, and W. F. van Gunsteren, “Def- inition and testing of the gromos force-field versions 54a7 and 54b7,” European biophysics journal , vol. 40, no. 7, pp. 843–856, 2011

    2011

  14. [22]

    Pubchem substance and compound databases,

    S. Kim, P. A. Thiessen, E. E. Bolton, J. Chen, G. Fu, A. Gindulyte, L. Han, J. He, S. He, B. A. Shoemaker, et al. , “Pubchem substance and compound databases,” Nucleic acids research, vol. 44, no. D1, pp. D1202–D1213, 2016

    2016

  15. [23]

    Open babel: An open chemical toolbox,

    N. M. O’Boyle, M. Banck, C. A. James, C. Morley, T. Vandermeersch, and G. R. Hutchison, “Open babel: An open chemical toolbox,” Journal of cheminformatics , vol. 3, no. 1, pp. 1–14, 2011

    2011

  16. [24]

    Prodrg: a tool for high-throughput crystallography of protein– ligand complexes,

    A. W. Sch¨ uttelkopf and D. M. Van Aalten, “Prodrg: a tool for high-throughput crystallography of protein– ligand complexes,” Acta Crystallographica Section D: Bi- ological Crystallography, vol. 60, no. 8, pp. 1355–1363, 2004

    2004

  17. [25]

    On the accurate calculation of the dielectric constant from molecular dynamics simu- lations: The case of spc/e and swm4-dp water,

    O. Gereben and L. Pusztai, “On the accurate calculation of the dielectric constant from molecular dynamics simu- lations: The case of spc/e and swm4-dp water,” Chemical Physics Letters, vol. 507, no. 1-3, pp. 80–83, 2011

    2011

  18. [26]

    Canonical sam- pling through velocity rescaling,

    G. Bussi, D. Donadio, and M. Parrinello, “Canonical sam- pling through velocity rescaling,” The Journal of chemical physics, vol. 126, no. 1, p. 014101, 2007

    2007

  19. [27]

    Polymorphic transitions in single crystals: A new molecular dynamics method,

    M. Parrinello and A. Rahman, “Polymorphic transitions in single crystals: A new molecular dynamics method,” Journal of Applied physics, vol. 52, no. 12, pp. 7182–7190, 1981

    1981

  20. [28]

    Particle mesh ewald: An n . log (n) method for ewald sums in large sys- tems,

    T. Darden, D. York, and L. Pedersen, “Particle mesh ewald: An n . log (n) method for ewald sums in large sys- tems,” The Journal of chemical physics , vol. 98, no. 12, pp. 10089–10092, 1993. p-9 M. G. Sahini et al

    1993

  21. [29]

    A smooth particle mesh ewald method,

    U. Essmann, L. Perera, M. L. Berkowitz, T. Darden, H. Lee, and L. G. Pedersen, “A smooth particle mesh ewald method,” The Journal of chemical physics, vol. 103, no. 19, pp. 8577–8593, 1995

    1995

  22. [30]

    P-lincs: A parallel linear constraint solver for molecular simulation,

    B. Hess, “P-lincs: A parallel linear constraint solver for molecular simulation,” Journal of chemical theory and computation, vol. 4, no. 1, pp. 116–122, 2008

    2008

  23. [31]

    Properties and reactivities of niclosamide in different media, a potential antiviral to treatment of covid-19 by using dft calculations and molecular docking,

    D. Romani, O. Noureddine, N. Issaoui, and S. A. Brand´ an, “Properties and reactivities of niclosamide in different media, a potential antiviral to treatment of covid-19 by using dft calculations and molecular docking,” Biointerface Res. Appl. Chem , vol. 10, no. 6, pp. 7295– ...

    2020

  24. [32]

    Soybean oil-based na- noemulsion systems in absence and presence of curcumin: Molecular dynamics simulation approach,

    F. Moghaddasi, M. R. Housaindokht, M. Darroudi, M. R. Bozorgmehr, and A. Sadeghi, “Soybean oil-based na- noemulsion systems in absence and presence of curcumin: Molecular dynamics simulation approach,” Journal of Molecular Liquids, vol. 264, pp. 242–252, 2018

    2018

  25. [33]

    Study of structural stability and formation mechanisms in dspc and dpsm liposomes: A coarse-grained molecular dynamics simulation,

    H. Hashemzadeh, H. Javadi, and M. Darvishi, “Study of structural stability and formation mechanisms in dspc and dpsm liposomes: A coarse-grained molecular dynamics simulation,” Scientific reports, vol. 10, no. 1, pp. 1–10, 2020

    2020

  26. [34]

    Fabrication of niclosamide loaded solid lipid nanoparticles: in vitro characterization and compar- ative in vivo evaluation,

    M. U. Rehman, M. A. Khan, W. S. Khan, M. Shafique, and M. Khan, “Fabrication of niclosamide loaded solid lipid nanoparticles: in vitro characterization and compar- ative in vivo evaluation,” Artificial cells, nanomedicine, and biotechnology, vol. 46, no. 8, pp. 1926–1934, 2018

    1926

  27. [35]

    Molecular dynamics simulations reveal mem- brane interactions for poorly water-soluble drugs: impact of bile solubilization and drug aggregation,

    A. Kabedev, S. Hossain, M. Hubert, P. Larsson, and C. A. Bergstr¨ om, “Molecular dynamics simulations reveal mem- brane interactions for poorly water-soluble drugs: impact of bile solubilization and drug aggregation,” Journal of Pharmaceutical Sciences, vol. 110, no. 1, pp. 17...

    2021

  28. [36]

    Learning force fields from stochastic trajectories,

    A. Frishman and P. Ronceray, “Learning force fields from stochastic trajectories,” Physical Review X, vol. 10, no. 2, p. 021009, 2020

    2020

  29. [37]

    Learning the dynamics of cell–cell interactions in confined cell migration,

    D. B. Br¨ uckner, N. Arlt, A. Fink, P. Ronceray, J. O. R¨ adler, and C. P. Broedersz, “Learning the dynamics of cell–cell interactions in confined cell migration,” Proceed- ings of the National Academy of Sciences , vol. 118, no. 7, p. e2016602118, 2021

    2021

  30. [38]

    Computer simulations of lipid nanoparticles,

    X. F. Fernandez-Luengo, J. Camacho, and J. Faraudo, “Computer simulations of lipid nanoparticles,” Nanoma- terials, vol. 7, no. 12, p. 461, 2017. p-10

    2017

Pith tools

Reviewed August 16, 2026 · model on record in the stance chip above.